USANA HEALTH SCIENCES INC's ticker is USNA and the CUSIP is 90328M107. A total of 195 filers reported holding USANA HEALTH SCIENCES INC in Q3 2020. The put-call ratio across all filers is 0.46 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $38,456,784 | -1.3% | 656,140 | +6.2% | 0.01% | +8.3% |
| Q2 2023 | $38,952,843 | +3.0% | 617,912 | +2.8% | 0.01% | -7.7% |
| Q1 2023 | $37,800,897 | +128741.8% | 600,975 | +9.0% | 0.01% | +44.4% |
| Q4 2022 | $29,339 | -99.9% | 551,476 | -2.0% | 0.01% | -25.0% |
| Q3 2022 | $31,555,000 | -22.9% | 562,969 | -0.5% | 0.01% | -20.0% |
| Q2 2022 | $40,953,000 | -9.0% | 565,966 | -0.1% | 0.02% | +7.1% |
| Q1 2022 | $45,002,000 | -21.2% | 566,420 | +0.4% | 0.01% | -17.6% |
| Q4 2021 | $57,080,000 | +7.6% | 564,030 | -2.0% | 0.02% | 0.0% |
| Q3 2021 | $53,071,000 | -10.4% | 575,616 | -0.5% | 0.02% | -10.5% |
| Q2 2021 | $59,233,000 | +2.2% | 578,284 | -2.7% | 0.02% | 0.0% |
| Q1 2021 | $57,981,000 | +23.0% | 594,072 | -2.9% | 0.02% | +11.8% |
| Q4 2020 | $47,149,000 | +6.2% | 611,532 | +1.4% | 0.02% | -10.5% |
| Q3 2020 | $44,403,000 | -1.5% | 602,928 | -1.8% | 0.02% | -5.0% |
| Q2 2020 | $45,072,000 | +23.8% | 613,862 | -2.6% | 0.02% | +5.3% |
| Q1 2020 | $36,405,000 | -27.9% | 630,287 | -2.0% | 0.02% | +5.6% |
| Q4 2019 | $50,506,000 | +15.4% | 642,974 | +0.4% | 0.02% | +5.9% |
| Q3 2019 | $43,785,000 | -10.8% | 640,215 | +3.6% | 0.02% | -10.5% |
| Q2 2019 | $49,062,000 | -5.3% | 617,694 | +0.0% | 0.02% | -9.5% |
| Q1 2019 | $51,804,000 | -29.9% | 617,677 | -1.6% | 0.02% | -36.4% |
| Q4 2018 | $73,880,000 | -13.9% | 627,549 | -11.8% | 0.03% | 0.0% |
| Q3 2018 | $85,782,000 | +2.4% | 711,582 | -2.0% | 0.03% | 0.0% |
| Q2 2018 | $83,753,000 | +25.4% | 726,385 | -6.6% | 0.03% | +17.9% |
| Q1 2018 | $66,771,000 | +18.2% | 777,313 | +1.9% | 0.03% | +21.7% |
| Q4 2017 | $56,473,000 | +30.3% | 762,621 | +1.5% | 0.02% | +21.1% |
| Q3 2017 | $43,334,000 | -4.9% | 751,018 | +5.6% | 0.02% | -9.5% |
| Q2 2017 | $45,570,000 | +13.8% | 710,918 | +2.3% | 0.02% | +10.5% |
| Q1 2017 | $40,042,000 | -4.6% | 695,170 | +1.4% | 0.02% | -9.5% |
| Q4 2016 | $41,976,000 | -9.8% | 685,877 | +103.8% | 0.02% | -16.0% |
| Q3 2016 | $46,554,000 | +31.5% | 336,497 | +5.9% | 0.02% | +25.0% |
| Q2 2016 | $35,399,000 | -13.6% | 317,687 | -5.9% | 0.02% | -20.0% |
| Q1 2016 | $40,979,000 | -5.5% | 337,501 | -0.5% | 0.02% | -7.4% |
| Q4 2015 | $43,343,000 | -6.3% | 339,274 | -1.7% | 0.03% | -10.0% |
| Q3 2015 | $46,277,000 | -1.9% | 345,266 | 0.0% | 0.03% | +3.4% |
| Q2 2015 | $47,185,000 | +22.7% | 345,266 | -0.2% | 0.03% | +20.8% |
| Q1 2015 | $38,457,000 | +8.3% | 346,081 | 0.0% | 0.02% | +4.3% |
| Q4 2014 | $35,505,000 | +37.2% | 346,081 | -1.5% | 0.02% | +27.8% |
| Q3 2014 | $25,869,000 | -6.4% | 351,194 | -0.7% | 0.02% | -5.3% |
| Q2 2014 | $27,639,000 | +3.8% | 353,714 | +0.0% | 0.02% | -5.0% |
| Q1 2014 | $26,640,000 | -1.2% | 353,602 | -0.9% | 0.02% | -4.8% |
| Q4 2013 | $26,968,000 | -14.3% | 356,804 | -1.5% | 0.02% | -22.2% |
| Q3 2013 | $31,453,000 | +19.7% | 362,404 | -0.2% | 0.03% | +8.0% |
| Q2 2013 | $26,272,000 | – | 362,977 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Euclidean Technologies Management, LLC | 34,732 | $3,563,000 | 3.33% |
| Matarin Capital Management, LLC | 28,322 | $2,905,554,000 | 1.28% |
| Capital Impact Advisors, LLC | 21,373 | $2,193,000 | 1.03% |
| USA FINANCIAL FORMULAS | 20,088 | $2,061,000 | 0.71% |
| Camarda Financial Advisors, LLC | 8,951 | $918,000 | 0.58% |
| Invictus RG Pte. Ltd. | 4,862 | $499,000 | 0.54% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 78,238 | $8,026,000 | 0.53% |
| Wolf Group Capital Advisors | 6,696 | $687,000 | 0.50% |
| RQSI Ltd | 3,937 | $404,000 | 0.38% |
| CLARK ESTATES INC/NY | 23,759 | $2,437,000 | 0.36% |